Literature DB >> 14697886

Tetrahydropapaveroline in Parkinson's disease and alcoholism: a look back in honor of Merton Sandler.

Michael A Collins1.   

Abstract

Although Dr. Merton Sandler's extensive and vigorous research program over the years has been concerned mainly with classical biogenic amines, monoamine oxidase (MAO), and MAO inhibitors, he and his group contributed a significant early Parkinson's disease-related study of a non-classical or "aberrant" biogenic amine. The formation and production of this amine, the dopamine-derived mammalian alkaloid, tetrahydropapaveroline (THP), is in fact dependent on MAO activity. As reviewed here, that study provided the groundwork for and indeed stimulated many later investigations of mammalian alkaloids in numerous laboratories around the world.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14697886     DOI: 10.1016/S0161-813X(03)00145-1

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  9 in total

1.  How human neuroblastoma cells make morphine.

Authors:  Chotima Boettcher; Monika Fellermeier; Christian Boettcher; Birgit Dräger; Meinhart H Zenk
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

2.  Urinary excretion of morphine and biosynthetic precursors in mice.

Authors:  Nadja Grobe; Marc Lamshöft; Robert G Orth; Birgit Dräger; Toni M Kutchan; Meinhart H Zenk; Michael Spiteller
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

Review 3.  Not Just from Ethanol. Tetrahydroisoquinolinic (TIQ) Derivatives: from Neurotoxicity to Neuroprotection.

Authors:  Alessandra T Peana; Valentina Bassareo; Elio Acquas
Journal:  Neurotox Res       Date:  2019-05-02       Impact factor: 3.911

Review 4.  Dopamine, morphine, and nitric oxide: an evolutionary signaling triad.

Authors:  George B Stefano; Richard M Kream
Journal:  CNS Neurosci Ther       Date:  2009-11-13       Impact factor: 5.243

5.  Acetaldehyde and parkinsonism: role of CYP450 2E1.

Authors:  Francesca Vaglini; Cristina Viaggi; Valentina Piro; Carla Pardini; Claudio Gerace; Marco Scarselli; Giovanni Umberto Corsini
Journal:  Front Behav Neurosci       Date:  2013-06-21       Impact factor: 3.558

6.  Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms.

Authors:  Young-Joon Surh; Hyun-Jung Kim
Journal:  Exp Neurobiol       Date:  2010-09-30       Impact factor: 3.261

7.  (R,S)-tetrahydropapaveroline production by stepwise fermentation using engineered Escherichia coli.

Authors:  Akira Nakagawa; Chiaki Matsuzaki; Eitaro Matsumura; Takashi Koyanagi; Takane Katayama; Kenji Yamamoto; Fumihiko Sato; Hidehiko Kumagai; Hiromichi Minami
Journal:  Sci Rep       Date:  2014-10-21       Impact factor: 4.379

Review 8.  The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain.

Authors:  W A García-Suástegui; L A Ramos-Chávez; M Rubio-Osornio; M Calvillo-Velasco; J A Atzin-Méndez; J Guevara; D Silva-Adaya
Journal:  Oxid Med Cell Longev       Date:  2017-01-10       Impact factor: 6.543

Review 9.  Parkinson's disease, L-DOPA, and endogenous morphine: a revisit.

Authors:  George B Stefano; Kirk J Mantione; Milena Králíčková; Radek Ptacek; Hana Kuzelova; Tobias Esch; Richard M Kream
Journal:  Med Sci Monit       Date:  2012-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.